Johnson & Johnson to buy medical device maker

Article Abstract:

Orthopedic device maker DePuy Inc. will be acquired by Johnson & Johnson, the major diversified health care manufacture, for $3.5 billion in cash. Roche Holding AG, which owns 84% of DePuy, will receive about $2.9 billion in the deal. Johnson & Johnson, which has suffered recent losses in its medical device business, is seeking to improve its position in the $9 billion orthopedic products market by becoming one of the leading makers of artificial joints and other body-part strengthening and replacement devices.

Comment:

Will acquire orthopedic device maker DePuy Inc. for $3.5 billion in cash

Acquisitions & mergers, Company Planning/Goals, Surgical Appliance and Supplies Manufacturing, Medical Equipment and Supplies Manufacturing, Medical Appliances & Supplies, Medical Instruments & Supplies, Medical equipment industry, Johnson & Johnson, Article, DePuy Inc.

---

Medpartners plans to divest itself of the business of physician practice management

Article Abstract:

Publicly traded Medpartners Inc. announced plans to give up trying to manage physician practices for health plans. The Birmingham, Alabama, firm will divest that portion of its business by selling it to hospitals, venture capitalists and back to the doctors involved. Instead it will concentrate on its managed drug plans and medical treatment management, more profitable units of its managed healthcare business.

Management services, Medical Management Services, Office Administrative Services, Mergers, acquisitions and divestments, Physicians, Medical professions, Abstract, Managed care plans (Medical care), Caremark Therapeutic Services, MPTR

---

Similar abstracts:

• Abstracts: The virtual general manager. The 'Americanization' of German Management. General management revisited
• Abstracts: P&G to give away Pringles with Olestra. Reader's Digest plans major changes in business structure, executive staff
• Abstracts: GPU Inc. is set to sell 23 power plants to Sithe Energies in $1.67 billion deal
• Abstracts: Pepsico to pay $3.3 billion for Tropicana. Pepsico studies possible conversion of bottling operations
• Abstracts: Suntrust to grow with purchase of Crestar. Life re agrees to be bought by Swiss Re

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.